In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Earnings Call Insights: Labcorp Holdings Inc. (NYSE:LH) Q4 2024 Labcorp reported revenue of $3.3 billion for Q4 2024, an increase of 10% year-over-year, with Diagnostics and Biopharma segments each ...
Zacks Investment Research on MSN
HOLX vs. LH: Which medtech stock is the stronger investment now?
Hologic HOLX and Labcorp LH are two established MedTech players with a history of collaboration, though each brings distinct strengths. With a market capitalization of $16.71 billion, Hologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback